Abx Flashcards
Penicillins
- MOA,
- Side Effects
MOA:
- Bind penicillin binding proteins
- Block transpeptidase cross-linking of cell wall
- Activate autolytic enzymes (Bactericidal)
Side Effects:
Hypersensitivity reaction (with cross alergenicity)
Hemolytic anemia
Penicillin G / Penicillin V
- Class
- Target Organism/Use,
- Administration route
Class - 1st generation PCNs
Target Orgs/Use:
Gram+ orgs (Grp A Strep, S. pneumoniae, Actinomyces);
Treponema pallidum (syphilis);
Bactericidal for Gram+ cocci, gram+ rods, gram- cocci and spirochetes
Administration:
PCN G - IV or IM (with anesthetic to increase t1/2)
PCN V - oral
Benzylpenicillin is AKA:
Penicillin G
Penicillin G is AKA:
Benzylpenicillin
penicillin V is AKA:
Phenoxymethylpenicillin
Methicillin / nafcillin / dicloxacillin / oxacillin
- Class
- Target Organisms/Use
- Side Effects,
- Administration route
Class -
2nd generation PCNs (narrow spectrum, b-lactamase resistant due to bulkier R-group)
Target Orgs/Use -
S. aureus (excep MRSA-altered penicillin binding protein)
Side Effects:
Methicillin - allergic interstitial nephritis Nafcillin/Oxacillin - hepatitis (some hepatic excretion)
Administration - Dicloxacillin oral
Amoxicillin/Ampicillin
- Class,
- Target Organisms/Use,
- Side Effects,
- Administration route
Class - Aminopenicillins - 3rd generation PCNs (wider spectrum than 1st gen, b-lactamase sensitive)
Target Orgs/Use:
Gram- rods and enterococcus:
“H.E.L.P.S. kill enterococcus” (H. flu, E. coli, Listeria, Proteus, Salmonella)
H. pylori triple therapy
Side Effects - hypersensitivity reactions, ampicillin rash, pseudomembranous colitis
Administration: Amoxicillin oral with food
Can be given with b-lactam inhibitor to enhance spectrum
Mezlocillin/Piperacillin
- Class,
- Target Orgs/Use
Class - 4th generation PCN (Ureidopenicillins) - Extended sprectrum, susceptible to b-lactamase (use w/ b-lactamase inhibitor)
Target Orgs/Use - Pseudomonas, and gram neg rods
Carbenicillin/Ticarcillin
- Class,
- Target Orgs/Use,
- Side Effects
Class - 4th generation PCN (Carboxypenicillins) - Extended spectrum, b-lactamase sensitive (use w/ b-lactamase inhibitor)
Target Orgs/Use - Pseudomonas, gram neg rods
Side Effects - Disodium salts that can produce large salt load
Clavulanic acid/Sulbactam/Tazobactam
- Class,
- MOA,
- Target Orgs/Use
Class - b-lactamase inhibitors (given in combination with b-lactam abx)
MOA - (No antimicrobial activity) covalent inhibitors of b-lactamase
Target Orgs/Use: Effective in conjunction with 3-4 gen PCN against Gram- b-lactamases and S. aureus
NOT effective for chromosomal b-lactamase of Pseudomonas, Enterobacter, Citrobacter, Serratia,
B-lactam Resistance mechanisms:
3 Strategies:
1. Decrease penetration - Gram- orgs let b-lactam in via porin - change porin to restrict entry (ex. Pseudomonas)
2. Alter PCN binding protein (ex. MRSA via mec locus, S. pneumoniae via transformation)
3. B-lactamase
Cephalosporins
- MOA,
- Side Effects
MOA - Bactericidal b-lactam drugs that inhibit cell wall synthesis, but less susceptible to penicillinases
Side Effects:
- Hypersensitivity reaction (5-10% cross hypersensitivity with PCN)
- Vitamin K deficiency (Cefotetan, Cefonicid, Cefoperazone)
- Disulfuram-like reaction w/ethanol (Cefotetan, Cefonicid, Cefoperazone)
- Increase the nephrotoxicity of Aminoglycosides
Cephalexin / Cephapirin / Cephalothin / Cefazolin
- Class,
- Target Orgs/Use,
- Metabolism
Class - 1st gen Cephalosporins
Target Orgs/Use -
Gram+ cocci (MSSA, Streptococci),
Enterobacteriaceae (“PEcK” - Proteus, E. coli, Klebsiella)
Metabolism:
Cephalothin - deacylated by liver (not good for meningitis, b/c deacylated form competes with active form for transport to CSF)
Cephapirin - deacylated by liver but w/ active metabolites
Cefuroxime/ Cefoxitin / Cefaclor / Cefotetan / Cefonicid
- Class,
- Target Orgs/Use,
- Side Effects
Class - 2nd Generation Cephalosporins
Target Orgs/Use: More stable vs. gram- orgs (HEN PEcKS - Haemophilus influenzae, Enterobacter, Neisseria, Proteus, E. coli, Klebsiella, Serratia) than 1st-gen cephalosporins
Less active vs. Gram+ cocci/S.aureus than 1st-gen
Side Effects: (Cefotetan/Cefonicid - MTT side chain ) 1. Inhibits Vitamin K mediated gamma carboxylation
- Associated with Disulfuram-like reaction with alcohol (throbbing of neck, headache, nausea, etc)
Ceftazidime / Ceftriaxone / Cefotaxime / Cefoperazone
- Class,
- Target Orgs/Uses,
- Side Effects,
- Metabolism
Class - 3rd generation Cephalosporins
Target Orgs/Uses: Broader activity vs. Gram- Ceftriaxone - meningitis and gonorrhea
Ceftazidime - Pseudomonas
Side Effects: (Cefoperazone - MTT side chain)
- Inhibits Vitamin K mediated gamma carboxylation
- Associated with Disulfuram-like reaction with alcohol (throbbing of neck, headache, nausea, etc)
Cefepime
- Class,
- Target Orgs/Uses
Class - 4th generation Cephalosporin
_Target Orgs/Uses_: More resistant to destruction by chromosomal b-lactamase Increased activity (over 3rd gen) vs. Pseudomonas and gram+
Aztreonam
- Class,
- MOA,
- Target Orgs/Use,
- Side Effects
Class - Monobactam
MOA -
b-lactam antibiotic (but only binds gram Neg transpeptidase PBP-3);
Inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking;
**resistant to (some, not all) b-lactamases
(synergistic** w/ aminoglycosides)
Target Orgs/Use -
Facultative Gram Neg bacteria (resistant to b-lactamase) -
Use for PCN-allergic pts; Safe to admininister aztreonam to patients with **hypersensitivity **(allergies) to penicillins and
those w/ renal insufficiency who cannot tolerate aminoglycosides;
Side Effects - Rare (diarrhea/rash),
NO cross-alergenicity with PCN,
Can trigger seizures in patients with history of seizures
Imipenem / Meropenem
- Class,
- MOA,
- Target Orgs/Use,
- Side Effects,
- Metabolism,
- Resistance
Class - Carbapenem
MOA - b-lactam antibiotic resistant to all b-lactamases
Target Orgs/Use: Broadest spectrum abx (but side effects limit use)
Imipenem - More active vs. Gram+ cocci
Meropenem - More activity vs. Gram- rods
Side Effects: Cross reactivity with PCN
Imipenem must be infused slowly or causes GI distress
Imipenem causes seizures (pts at increase risk - renal insufficiency)
Metabolism: Imipenem - hydrolyzed by peptidase on renal tubular cells (coadmin with cilastatin - dipeptidase inhibitor)
Resistance: Pseudomonas - porin mutation Carbapenemase may arise
Vancomycin
- MOA,
- Target Orgs/Use,
- Side Effects,
- Administration,
- Metabolism,
- Resistance
MOA - Inhibits cell wall mucopeptide formation, by binding to D-ala-D-ala portion of the cell wall precursors. Bactericidal.
Target Orgs/Use: Gram+ bacteria including MRSA and Enterococcus
Used for all gram+ infections in PCN allergic pt
Used oral to treat C. difficile
Side Effects: (NOT many)
Nephrotoxicity (especially with aminoglycosides)
Ototoxic
Thrombophlebitis
“Red man syndrome” (HM release) - diffuse flushing (prevent w/antiHM and slow infusion)
Administration - Given IV (except for to tx C. diff)
_Resistance_: Block penetration (Gram- bacteria mode of resistance) Plasmid genes altering structure of cell wall to D-ala-D-lac (some Gram+ strains)
In Pharm, Intrathecal refers to:
a route of administration for drugs via an injection into the spinal canal,
more specifically into the subarachnoid space so that it reaches the CSF
Chloramphenicol
- MOA,
- Target Orgs/Use,
- Side Effects,
- Resistance
MOA - Bacteriostatic, Inhibits protein synthesis by: binds to the 23S rRNA part of the 50S ribosome and inhibits peptide bond formation
Target Orgs/Use - Broad spectrum used in developing world (not used in US) for Meningitis (covers H. flu, N. meningiditis, S. pneumoniae)
Side Effects:
Dose-dependent irreversible aplastic anemia and reversible BM suppression,
“Gray baby syndrome” due to failure of glucuronidation in liver of neonates (can lead to circulatory collapse and death),
Hemolysis in pts with G6PD deficiency
Resistance - plasmid-encoded acetyl transferase that inactivates drug
Clindamycin
- MOA,
- Target Orgs/Use,
- Side Effects,
- Resistance
MOA - Bacteriostatic, binds to 23S rRNA portion on the 50S ribosomal subunit and blocks chain elongation (peptide bond formation)
Target Orgs/Use - Anaerobes (above diaphragm - aspiration pneumonia/lung abscess)
Side Effects - Pseudomembranous colitis due to overgrowth of C. diff
Resistance - Plasmid encoded resistance due to methylation of 23S rRNA binding site, leading to decreased binding by clindamycin
Linezolid
- MOA,
- Target Orgs/Use,
- Side Effects
MOA - Binds 23S portion of 50S ribosomal subunit and blocks formation of initiation complex
Target Orgs/Use - Gram+ cocci (including MRSA, VRE and b-lactam resistant pneumococcal disease)
Side Effects - BM suppression, MAO inhibitor (toxicity with tyramine or other related drugs)
Erythromycin, Azithromycin, Clarithromycin
- Class,
- MOA,
- Target Orgs/Use,
- Side Effects,
- Resistance
Class - Macrolide (Inhibitor of protein synthesis), Azithromycin/Clarithromycin are long-acting
MOA - Bacteriostatic, binds to 23S rRNA on 50S ribosomal subunit and blocks chain elongation (blocks translocation)
_Target Orgs/Use_: Atypical pneumonias (mycoplasma, chlamydia, legionella) URIs, STDs Gram+ cocci (strep infections in pts allergic to PCN) Neisseria Azithromycin - MAC (M. avium intracellulare) prophylaxis and treatment
Side Effects:
Nausea/Diarrhea (motilin agonist) - worse w/ Erythromycin
Cholestatic hepatitis
Inhibits P-450 enzymes - increases concentration of warfarin and theophylline [*Azithromycin is an EXCEPTION b/c it does Not inhibit CYP3A4],
Eosinophilia, skin rash ,
QT prolongation (mostly Erythromycin) ,
Teratogen (Clarithromycin)
Resistance: Plasmid encoded resistance due to methylation of 23S rRNA -< decreased binding